Monday 12 October 2026 Export all AMGN data to Excel Powerpack

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

414.87 7.43 +1.82%
Market cap
$224.3B
P/E
25.6×
Fwd P/E
22.7×
Dividend yield
2.40%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
91.47% 101.32% 106.10% 81.71%

+8 more TTM periods

Piotroski F-Score
8 8 7 7
ROA
9.53% 8.58% 8.45% 7.74%
ROIC
12.98% 12.12% 10.48% 9.90%
Return on Tangible Assets
48.56% 52.93% 67.16% 52.61%
Average Days of Receivables
97.99 89.61 95.05 86.15
Free Cash Flow per Share
18.84 15.92 15.06 21.45
Free Cash Flow
10,175.00 8,597.00 8,100.00 11,539.00
Capital Expenditures
(2,303.00) (2,159.00) (1,858.00) (1,587.00)
Other line items
Cash ROIC
12.26% 10.94% 11.19% 15.67%
Accounts Receivable Turnover
4.03 4.31 4.50 4.55
Accounts Payable Turnover
3.95 4.42 5.63 4.88
Inventory Turnover
1.81 1.83 1.82 1.78
Average Days of Payables
90.05 90.69 71.77 85.10
Days of Inventory on Hand
195.50 191.14 188.76 190.28
Tax Rate
(0.15) (0.14) (0.14) (0.15)
Research and Development Expense of Revenue
20.03% 20.16% 19.79% 19.05%
Selling, General and Administrative Expense of Revenue
18.42% 18.71% 19.18% 19.39%
Share Based Compensation of Revenue
1.29% 1.30% 1.34% 1.40%
Interest Coverage
4.28 3.93 3.30 3.04
Operating CF/Net income
1.43 1.38 1.29 1.87
Depreciation/Fixed assets
0.59 0.64 0.80 0.92
Capex/Depreciation
(0.45) (0.41) (0.29) (0.24)
Revenue per Share
70.55 68.93 68.31 66.86
Operating CF per Share
23.11 19.92 18.51 24.40
Capex per Share
(4.26) (4.00) (3.45) (2.95)
Capex to Sales
0.06 0.06 0.05 0.04

Fold the line items

Columns are period end dates